Back

Impact of beta-blocker nebivolol versus carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with reduced LVEF treated with drug-eluting stents

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in acute coronary syndromes (4) ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Soohyung Park

Korea University Guro Hospital, Seoul (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Aspirin does not reduce cardiovascular risk in smokers across coronary calcium scores after coronary computed tomography angiography
Mr G. Winther (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy presenting with ACS - a systematic review and meta-analysis
Doctor B. Hakkeem (Kozhikode, IN)
Abstract Slides Video
Presentation thumbnail
Safety and effectiveness of tegoprazan in patients treated with dual antiplatelet therapy after drug-eluting stent implantation for acute myocardial infarction.
Doctor O. Lee (Yongin, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in acute coronary syndromes (4)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents
thumbnail
Congress Presentation
Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents
thumbnail
Congress Presentation
Impact of 2nd-generation versus 3rd-generation beta-blockers on long-term clinical outcomes in STEMI patients treated with drug-eluting stents

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources